ライフサイエンスツールと試薬の世界市場

Report Highlights

The global market for life science tools and reagents, including COVID-19 diagnostics was valued at $59.4 billion in 2023. This market is expected to grow from $53.2 billion in 2024 to reach $66.5 billion by the end of 2029, at a CAGR of 4.6% during the forecast period of 2024-2029.

Report Ovewview

Report Scope
This report provides an analysis of the market for life sciences tools and reagents, including the leading companies, their revenues, product portfolios and recent activities. It looks at the competitive landscape and market dynamics such as drivers, restraints and opportunities. It sizes of the current and future markets. The reagents studied are antibodies, enzyme-linked immunosorbent assay (ELISA) kits, protein reagents and probes. The life science instruments include hybridization systems, PCR, Western blotting instruments, and ELISA instruments. The regions whose markets are analyzed are North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Markets are also analyzed by application.
Report Includes
– 85 data tables and 44 additional tables
– An analysis of the global markets for life science tools and reagents, including COVID-19 diagnostics products
– Analyses of the global market trends, with market revenue data (sales figures) from 2021 to 2023, estimates for 2024, and projected CAGRs through 2029
– An estimate of the market size and revenue forecast for the market for life science tools and diagnostics, and a corresponding market share analysis based on product type, application and region
– Highlights of the current and future market potential of life science tools and diagnostics, along with an analysis of the competitive landscape, regulatory scenario and technological advances
– Facts and figures pertaining to the market dynamics, opportunities and deterrents, emerging technologies, future prospects and the impacts of macroeconomic variables
– An assessment of current products and identification of new potential markets for novel products and assay development
– A discussion on how scientific trends, government policies and the economy in general affect this market, as well as how the life science tools and diagnostics industry differs from the pharmaceutical and drug discovery industry
– A discussion of sustainability trends in the market, with emphasis on consumer attitudes, an analysis of companies’ ESG scores, the future of ESG, case studies, and the ESG practices of leading companies
– An analysis of the key patent grants and recently published patents
– Identification of the major vendors along with an analysis of the competitive landscape, including company market shares, recent M&A activity and the outlook for venture funding
– Profiles of the leading market players, including Thermo Fisher Scientific, Danaher Corp., Merck KGaA, Roche and Qiagen

Table of Contents

Table of Contents

Chapter 1 Executive Summary

Market Outlook

Scope of Report

Market Summary

Chapter 2 Market Overview

Overview

Product Development in Life Science

PESTLE Analysis

Political

Economic

Social

Technological

Environmental

Legal

Environmental

Porter’s Five Forces Analysis

Bargaining Power of Buyers

Bargaining Power of Suppliers

Potential for New Entrants

Threat of Substitutes

Competition in the Industry

Chapter 3 Market Dynamics

Market Dynamics Snapshot

Market Drivers

Increasing Investments in R&D

Diagnostic Pathways

Prevalence of Chronic Diseases

Broadening Range of Applications

Market Restraints

End of COVID-19 pandemic

Cybersecurity

Lack of Reproducibility of Antibodies

Market Challenges

End Users and Regulatory Compliance

Market Opportunities

Infectious Diseases on the Rise

New Technologies

Chapter 4 Emerging Technologies and Developments

AI and Machine Learning

Internet of Things (IoT)

Automation of Data Collection

Tracking of Equipment

Remote Analysis

Interconnectivity

Predictive Maintenance

Robots in Life Science Labs

3D/4D Cell Culturing

Reduced Use of Harmful Chemicals

Chapter 5 Market Segmentation Analysis

Segmental Breakdown

Market Analysis by Type

COVID-19 Diagnostic Tests Market

Market for Life Science Tools and Reagents

Market Breakdown by Application

Genomics

Proteomics

Cell Biology

Stem Cells

Imaging Tools and Techniques

Animal Models

Epigenetics Tools and Reagents

Metabolomics

Other Applications

Geographic Breakdown

Market Analysis by Region

North America

Europe

Asia-Pacific

Rest of the World

Chapter 6 Competitive Intelligence

Analysis of Leading Companies

PCR Technologies and Reagents

Microplate Readers/ELISA Instruments

Antibodies

ELISA Tests

Life Science Kits and Assays

COVID-19 Diagnostics

Strategic Analysis

Product Introductions

Collaborations and Agreements

Mergers and Acquisitions

Other Strategic Developments

Chapter 7 Sustainability in the Life Sciences Tools and Reagents Market: An ESG Perspective

Introduction to ESG

Environment

Social Issues

Governance

ESG Performance Analysis in the Life Science Tools and Reagents Industry

Packaging

ESG Risk Ratings

ESG-related Opportunities and Risks

Concluding Remarks from BCC Research

Chapter 8 Appendix

Methodology

Abbreviations

Sources

Company Profiles

BD

BIO-RAD LABORATORIES INC.

DANAHER CORP.

1. HOFFMANN-LA ROCHE LTD.

MERCK KGAA

PROMEGA CORP.

QIAGEN

REVVITY

TAKARA BIO INC.

THERMO FISHER SCIENTIFIC INC.

List Of Tables

List of Tables

Summary Table : Global Market for Life Science Tools and Reagents and COVID-19 Diagnostics, by Type, Through 2029

Table 1 : Differences Between Basic and Applied Research

Table 2 : Pandemics of the 21st Century

Table 3 : Global Market for Life Science Tools and Reagents and COVID-19 Diagnostics, by Type, Through 2029

Table 4 : Global Market for COVID-19 Diagnostics Tests, by Type, Through 2029

Table 5 : Global Market for COVID-19 Molecular Tests, by Region, Through 2029

Table 6 : North American Market for COVID-19 Molecular Tests, by Country, Through 2029

Table 7 : European Market for COVID-19 Molecular Tests, by Country, Through 2029

Table 8 : Asia-Pacific Market for COVID-19 Molecular Tests, by Country, Through 2029

Table 9 : Global Market for COVID-19 Antigen Tests, by Region, Through 2029

Table 10 : North American Market for COVID-19 Antigen Tests, by Country, Through 2029

Table 11 : European Market for COVID-19 Antigen Tests, by Country, Through 2029

Table 12 : Asia-Pacific Market for COVID-19 Antigen Tests, by Country, Through 2029

Table 13 : Global Market for COVID-19 Serological Tests, by Region, Through 2029

Table 14 : North American Market for COVID-19 Serological Tests, by Country, Through 2029

Table 15 : European Market for COVID-19 Serological Tests, by Country, Through 2029

Table 16 : Asia-Pacific Market for COVID-19 Serological Tests, by Country, Through 2029

Table 17 : Global Market for Life Science Tools and Reagents, by Type, Through 2029

Table 18 : Global Market for Life Science Tools and Reagents, by Region, Through 2029

Table 19 : North American Market for Life Science Tools and Reagents, by Country, Through 2029

Table 20 : European Market for Life Science Tools and Reagents, by Country, Through 2029

Table 21 : Asia-Pacific Market for Life Science Tools and Reagents, by Country, Through 2029

Table 22 : Global Market for Life Science Instruments, by Region, Through 2029

Table 23 : North American Market for Life Science Instruments, by Country, Through 2029

Table 24 : European Market for Life Science Instruments, by Country, Through 2029

Table 25 : Asia-Pacific Market for Life Science Instruments, by Country, Through 2029

Table 26 : Global Market for Life Science Reagents and Kits, by Region, Through 2029

Table 27 : North American Market for Life Science Reagents and Kits, by Country, Through 2029

Table 28 : European Market for Life Science Reagents and Kits, by Country, Through 2029

Table 29 : Asia-Pacific Market for Life Science Reagents and Kits, by Country, Through 2029

Table 30 : Global Market for Life Science Tools and Reagents, by Application, Through 2029

Table 31 : Global Market for Genomics, by Region, Through 2029

Table 32 : North American Market for Genomics, by Country, Through 2029

Table 33 : European Market for Genomics, by Country, Through 2029

Table 34 : Asia-Pacific Market for Genomics, by Country, Through 2029

Table 35 : Global Market for Proteomics, by Region, Through 2029

Table 36 : North American Market for Proteomics, by Country, Through 2029

Table 37 : European Market for Proteomics, by Country, Through 2029

Table 38 : Asia-Pacific Market for Proteomics, by Country, Through 2029

Table 39 : Global Market for Cell Biology, Antibodies and Recombinant Proteins, by Region, Through 2029

Table 40 : North American Market for Cell Biology, Antibodies and Recombinant Proteins, by Country, Through 2029

Table 41 : European Market for Cell Biology, Antibodies and Recombinant Proteins, by Country, Through 2029

Table 42 : Asia-Pacific Market for Cell Biology, Antibodies and Recombinant Proteins, by Country, Through 2029

Table 43 : Global Market for Stem Cell Research, by Region, Through 2029

Table 44 : North American Market for Stem Cell Research, by Country, Through 2029

Table 45 : European Market for Stem Cell Research, by Country, Through 2029

Table 46 : Asia-Pacific Market for Stem Cell Research, by Country, Through 2029

Table 47 : Global Market for Imaging Tools and Techniques, by Region, Through 2029

Table 48 : North American Market for Imaging Tools and Techniques, by Country, Through 2029

Table 49 : European Market for Imaging Tools and Techniques, by Country, Through 2029

Table 50 : Asia-Pacific Market for Imaging Tools and Techniques, by Country, Through 2029

Table 51 : Global Market for Animal Models, by Region, Through 2029

Table 52 : North American Market for Animal Models, by Country, Through 2029

Table 53 : European Market for Animal Models, by Country, Through 2029

Table 54 : Asia-Pacific Market for Animal Models, by Country, Through 2029

Table 55 : Global Market for Epigenetic Tools and Reagents, by Region, Through 2029

Table 56 : North American Market for Epigenetic Tools and Reagents, by Country, Through 2029

Table 57 : European Market for Epigenetic Tools and Reagents, by Country, Through 2029

Table 58 : Asia-Pacific Market for Epigenetic Tools and Reagents, by Country, Through 2029

Table 59 : Global Market for Metabolomics, by Region, Through 2029

Table 60 : North American Market for Metabolomics, by Country, Through 2029

Table 61 : European Market for Metabolomics, by Country, Through 2029

Table 62 : Asia-Pacific Market for Metabolomics, by Country, Through 2029

Table 63 : Global Market for Other Applications of Life Science Tools and Reagents, by Region, Through 2029

Table 64 : North American Market for Other Applications of Life Science Tools and Reagents, by Country, Through 2029

Table 65 : European Market for Other Applications of Life Science Tools and Reagents, by Country, Through 2029

Table 66 : Asia-Pacific Market for Other Applications of Life Science Tools and Reagents, by Country, Through 2029

Table 67 : Global Market for Life Science Tools and Reagents, by Region, Through 2029

Table 68 : North American Market for Life Science Tools and Reagents, by Country, Through 2029

Table 69 : North American Market for Life Science Tools and Reagents, by Type, Through 2029

Table 70 : North American Market for COVID-19 Diagnostics, by Country, Through 2029

Table 71 : European Market for Life Science Tools and Reagents, by Country, Through 2029

Table 72 : European Market for Life Science Tools and Reagents, by Type, Through 2029

Table 73 : European Market for COVID-19 Diagnostics, by Country, Through 2029

Table 74 : Asia-Pacific Market for Life Science Tools and Reagents, by Country, Through 2029

Table 75 : Asia-Pacific Market for Life Science Instruments and Reagents, by Type, Through 2029

Table 76 : Asia-Pacific Market for COVID-19 Diagnostics, by Country, Through 2029

Table 77 : RoW Market for Life Science Instruments and Reagents, by Type, Through 2029

Table 78 : Ranking of Life Science Tool and Reagent Companies, by Revenue, 2023

Table 79 : Leading Providers of PCR Technologies, by Revenue, 2023

Table 80 : Leading Providers of ELISA Instruments/Microplate Readers, by Revenue, 2023

Table 81 : Leading Suppliers of Antibodies, by Revenue, 2023

Table 82 : Leading Providers of ELISA Tests, by Revenue, 2023

Table 83 : Leading Providers of Kits and Assay Tests, by Revenue, 2023

Table 84 : Leading Providers of COVID-19 Diagnostics Tools, by Revenue, 2023

Table 85 : Recent New Life Science Tools and Reagents, 2022–2024

Table 86 : Collaborations in the Life Science Tools and Reagents Market, 2021–2024

Table 87 : Recent Acquisitions in the Market for Life Science Tools and Reagents, 2021–2024

Table 88 : Other Recent Developments in the Life Science Tools and Reagents Market, 2021–2024

Table 89 : ESG Ratings of the Leading Providers of Life Science Tools and Reagents

Table 90 : List of Abbreviations Used in the Report

Table 91 : Report Sources

Table 92 : BD: Company Snapshot

Table 93 : BD: Financial Performance, FY 2022 and 2023

Table 94 : BD: Product Portfolio

Table 95 : BD: News/Key Developments, 2021-2024

Table 96 : Bio-Rad Laboratories Inc.: Company Snapshot

Table 97 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023

Table 98 : Bio-Rad Laboratories Inc.: Product Portfolio

Table 99 : Bio-Rad Laboratories Inc.: News/Key Developments, 2022 and 2023

Table 100 : Danaher Corp.: Company Snapshot

Table 101 : Danaher Corp.: Financial Performance, FY 2022 and 2023

Table 102 : Danaher Corp.: Product Portfolio

Table 103 : Danaher Corp.: News/Key Developments, 2021–2023

Table 104 : F. Hoffmann-La Roche Ltd.: Company Snapshot

Table 105 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023

Table 106 : F. Hoffmann-La Roche Ltd.: Product Portfolio

Table 107 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2021–2023

Table 108 : Merck KGaA: Company Snapshot

Table 109 : Merck KGaA: Financial Performance, FY 2022 and 2023

Table 110 : Merck KGaA: Product Portfolio

Table 111 : Merck KGaA: News/Key Developments, 2021 and 2022

Table 112 : Promega Corp.: Company Snapshot

Table 113 : Promega Corp.: Product Portfolio

Table 114 : Promega Corp.: News/Key Developments, 2023 and 2024

Table 115 : Qiagen: Company Snapshot

Table 116 : Qiagen: Financial Performance, FY 2022 and 2023

Table 117 : Qiagen: Product Portfolio

Table 118 : Revvity: Company Snapshot

Table 119 : Revvity: Financial Performance, FY 2022 and 2023

Table 120 : Revvity: Product Portfolio

Table 121 : Revvity: News/Key Developments, 2023 and 2024

Table 122 : Takara Bio Inc.: Company Snapshot

Table 123 : Takara Bio Inc.: Financial Performance, FY 2022 and 2023

Table 124 : Taraka Bio Inc.: Product Portfolio

Table 125 : Thermo Fisher Scientific Inc.: Company Snapshot

Table 126 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023

Table 127 : Thermo Fisher Scientific Inc.: Product Portfolio

Table 128 : Thermo Fisher Scientific Inc.: News/Key Developments, 2021–2024

List Of Figures

List of Figures

Summary Figure : Global Market for Life Science Tools and Reagents and COVID-19 Diagnostics, by Type, 2021–2029

Figure 1 : Market Dynamics of Life Sciences Tools and Reagents Market

Figure 2 : R&D Spending, by Academic Institutions, 2021–2022

Figure 3 : Venture Capital Funding in Life Science, 2021–2022

Figure 4 : New Diagnostic Techniques

Figure 5 : Percentage of Deaths from Non-Communicable Diseases, by Income Level, 2023

Figure 6 : Reasons for Increase in Pandemics

Figure 7 : Global Market Shares of COVID-19 Diagnostics, by Type, 2023

Figure 8 : Types of ELISA

Figure 9 : Global Market for Life Science Tools and Reagents, by Application, 2024 and 2029

Figure 10 : Global Market for Life Science Tools and Reagents, by Region, 2021–2029

Figure 11 : U.S. Spendings on Life Sciences R&D, 2001 vs. 2019

Figure 12 : U.S. Market for Life Science Tools and Diagnostics, 2021–2029

Figure 13 : Canadian Market for Life Science Tools and Diagnostics, 2021–2029

Figure 14 : Mexican Market for Life Science Tools and Diagnostics, 2021–2029

Figure 15 : U.K. Market for Life Science Tools and Diagnostics, 2021–2029

Figure 16 : German Market for Life Science Tools and Diagnostics, 2021–2029

Figure 17 : French Market for Life Science Tools and Diagnostics, 2021–2029

Figure 18 : Rest of the European Market for Life Science Tools and Diagnostics, 2021–2029

Figure 19 : Chinese Population Aging Over 60, 2019 and 2040

Figure 20 : Chinese Market for Life Science Tools and Diagnostics, 2021–2029

Figure 21 : Share of Aging Population in Japan, 2019 and 2040

Figure 22 : Japanese Market for Life Science Tools and Diagnostics, 2021–2029

Figure 23 : Indian Market for Life Science Tools and Diagnostics, 2021–2029

Figure 24 : Rest of Asia-Pacific Market for Life Science Tools and Diagnostics, 2021–2029

Figure 25 : Factors Impacting the Environment

Figure 26 : BD: Revenue Share, by Business Unit, FY 2023

Figure 27 : BD: Revenue Share, by Country/Region, FY 2023

Figure 28 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023

Figure 29 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023

Figure 30 : Danaher Corp.: Revenue Share, by Business Unit, FY 2023

Figure 31 : Danaher Corp.: Revenue Share, by Country/Region, FY 2023

Figure 32 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023

Figure 33 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023

Figure 34 : Merck KGaA: Revenue Share, by Business Unit, FY 2023

Figure 35 : Merck KGaA: Revenue Share, by Country/Region, FY 2023

Figure 36 : Qiagen: Revenue Share, by Business Unit, FY 2023

Figure 37 : Qiagen: Revenue Share, by Country/Region, FY 2023

Figure 38 : Revvity: Revenue Share, by Business Unit, FY 2023

Figure 39 : Revvity: Revenue Share, by Country/Region, FY 2023

Figure 40 : Takara Bio Inc.: Revenue Share, by Business Unit, FY 2023

Figure 41 : Takara Bio Inc.: Revenue Share, by Country/Region, FY 2023

Figure 42 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023

Figure 43 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023

BCC Research（BCCリサーチ）はライフサイエンス、センサ、マテリアル、環境、商取引関連市場を中心とした広範な市場調査レポートを出版する米国の調査会社です。

ライセンス別価格表

2024年11月より価格構成が大幅に変更になりました。最新の価格についてはお問合せください。

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

新価格表

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

旧価格表

旧ライセンスタイプ1

旧ライセンスタイプ2

ご購入に関するご案内

価格・納期について

• 価格
• ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • 2-5ライセンス
    • 同一企業内5名までレポートファイルのご利用が可能です。
  • サイトライセンス
    • 同一企業同住所内でレポートファイルのご利用が可能です。
  • エンタープライズライセンス
    • 同一企業内人数無制限でレポートファイルのご利用が可能です。
• 納品形態
  • Eメール
• 納期
  • ご注文後3営業日以内

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

BCC Researchが出版する調査レポートのサンプルページのご依頼、見積り、ご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 食品小売業およびEコマースにおけるAIの世界市場 2025-11-14
• 免疫療法薬の世界市場 2025-11-12
• 農業におけるAIの世界市場 2025-11-10
• 固体酸化物形燃料電池の技術と世界市場 2025-11-07
• 世界の電気アーク炉市場 2025-11-07

BCC Research  出版レポート一覧